Punjab Chemicals & Crop Protection Ltd

- No specific new fundraising through debt or equity has been finalized or disclosed. - The company is currently servicing existing term loans and has increased working capital facilities with new bank sanctions. - Debt equity ratio remains comfortable at 0.35. - They continue to scout for new sites for expansion, potentially Brownfield or Greenfield, but plan to time investments based on market revival. - Capex of around INR50 crores is planned for FY25 at existing sites for capacity enhancement and efficiency, funded from internal accruals. - No mention of planned equity raising or new debt issuance during the call or presentation.

- FY25 Capex outlay of around INR 50 crores planned for existing sites focused on capacity enhancement, efficiency improvement, and setting up a new manufacturing block. - The INR 50 crores capex is incremental and aimed at brownfield projects within existing premises, including additional blocks. - Scouting for a new site (Brownfield preferred, but Greenfield also considered) is ongoing; timing of this investment depends on industry revival and market conditions. - New site development typically takes 12-18 months due to approvals and commissioning; decision will be made when market visibility improves. - Existing site expansions and new product introductions expected to drive incremental sales of INR 1,000-1,200 crores over 1-3 years, supported by the capex. - Capex funded through internal accruals with no major finalized greenfield investment yet. - Vigilant approach toward additional large capex awaits market normalization and clear demand signals.

- Additional sales of INR 1,000 to INR 1,200 crores expected from CRAMS over the next 1 to 3 years. - Existing facilities (three sites) have some space for 10-15% growth in existing products; 80% of growth expected from new products. - Around INR 200 crores additional capex anticipated, mainly through brownfield expansions on existing premises. - Growth in existing products projected at 8-10% annually. - New products could contribute an additional INR 200-250 crores in revenues. - Product introductions continue at a rate of 2-3 new products every six months, with commercialization expected to scale up gradually. - Volume decline of about 8% in FY24; price correction largely responsible for revenue impact. - Market demand expected to recover starting second half of FY25, with price stabilization and gradual uptick. - Capacity expansions include adding multipurpose blocks and scouting new sites with 12-18 months lead time.

- New products contributed 7% to sales in FY24, expected to scale up further with healthy growth prospects. - Existing products projected to grow at 8% to 10% in FY25. - New products are expected to add INR 200-250 crores in additional revenues in FY25. - Gross margins improved from 36.8% (FY23) to 38.7% (FY24) due to efficiency improvements; expected to recover further as market stabilizes. - EBITDA margins maintained at 12.1% (FY24), on par with FY23 despite challenging market conditions. - Management confident in continued margin improvement backed by R&D, operational excellence, and product mix optimization. - Long-term contracts and CRAMS (Contract Research and Manufacturing Services) could add INR 1,000-1,200 crores revenue over 1-3 years. - Asset turns estimated at 3-4x; incremental capex around INR 200 crores expected to support this growth. - Outlook is cautiously optimistic with focus on innovation, sustainability, and market adaptability.

- Punjab Chemicals and Crop Protection Limited is actively engaging in discussions for long-term contracts. - Several contracts have already been signed, with more expected to be finalized. - The company does not disclose specific numbers on order books during calls for confidentiality reasons. - Upon materialization of these contracts, visibility will be provided for durations between 1 to 3 years. - Broadly, the company is targeting an order book size between INR 1,000 crores to INR 1,200 crores over the next 1 to 2 years.